Systemic lupus erythematosus
Conditions
Sponsors
Zhejinag University of f Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) meet the diagnostic criteria of RA, activity period and abnormal heart function; (2) between the ages of 18 and 60; (3) if taking NSAIDs, the dose has been stable for at least 4 weeks; if not, it has been stable for at least 1 week; (4) if you take MTX, you have been treated with MTX3 for at least 4 months, and the dose is fixed at 10mg/ week for at least 4 weeks.If you take LEF, you have been treated with leff for at least 3 months, and the dose is fixed at 10mg/ day for at least 4 weeks. (5) if glucocorticoid is taken, the dose (compared with prednisone) must be less than 15mg/ day and has been used for at least 4 weeks; (6) participate in the study voluntarily and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) intramuscular injection or intravenous drip of glucocorticoids within 4 weeks; (2) das28-3 score > 5.1 (high activity); (3) patients with other rheumatic diseases such as systemic lupus erythematosus, sjogren's syndrome and gout; (4) pregnant or nursing women or those who plan to give birth in the near future; (5) allergic to the test drugs; (6) those who have participated in other clinical trials recently (within 1 month); (7) mental patients and people without capacity for civil conduct.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SLEDAI; | — |
Countries
China
Contacts
Public ContactWang Wei-jie
Outcome results
None listed